AbstractRopinirole, a D2/D3 receptor agonist has been reported to have neuroprotective effects. We showed that ropinirole can prevent rotenone-induced apoptosis in dopaminergic cell line SH-SY5Y through D3 receptor. We found that ropinirole can block the rotenone-induced phosphorylation of JNK, P38 and p-c-Jun, but promote the phosphorylation of ERK1/2. Furthermore, we demonstrated that ropinirole can reduce the rotenone-induced cleavages of caspase 9, caspase 3 and PARP and elevate the expression of anti-apoptotic proteins of p-Akt and bcl-2. These results provide a basis for neuroprotection by this drug for the treatment of Parkinson disease
Ginsenoside-Rg1, the pharmacologically active component isolated from ginseng, demonstrated neuropro...
Parkinson disease (PD) is a complex neurodegenerative disorder characterized by a progressive loss o...
Dopamine replacement therapy for Parkinson's disease is achieved using L-DOPA or dopamine D2/3 agoni...
AbstractRopinirole, a D2/D3 receptor agonist has been reported to have neuroprotective effects. We s...
AbstractRopinirole, an agonist of the post-synaptic dopamine D2-receptor, exerts neuroprotective act...
As part of our long-term objective and continued efforts in developing an efficient multifunctional ...
The antiparkinsonian ropinirole and pramipexole are D3 receptor- (D3R-) preferring dopaminergic (DA)...
With L-DOPA, dopamine agonists such as pramipexole, ropinirole and rotigotine constitute key therape...
To date, the lack of highly selective antagonists at the dopamine D 3 receptor has hampered clarific...
A pharmacological and genetic blockade of the dopamine D3 receptor (D3R) has shown to be neuroprotec...
3-methyl-6-chloro-7,8-hydroxy-1-(3-methylphenyl)-2,3,4,5-tetrahydro-1H-3 - benzazepine (SKF83959), a...
Parkinson’s disease (PD) is characterized by a loss of dopaminergic neurons in the substantia nigra ...
Geniposide, a monomer extracted from gardenia and widely used in Chinese medicine, is a novel agonis...
We have investigated the ability of pramipexole, a dopamine agonist used in the symptomatic treatmen...
Parkinson’s disease is characterized by the loss of dopaminergic neurons in substantia nigra pars co...
Ginsenoside-Rg1, the pharmacologically active component isolated from ginseng, demonstrated neuropro...
Parkinson disease (PD) is a complex neurodegenerative disorder characterized by a progressive loss o...
Dopamine replacement therapy for Parkinson's disease is achieved using L-DOPA or dopamine D2/3 agoni...
AbstractRopinirole, a D2/D3 receptor agonist has been reported to have neuroprotective effects. We s...
AbstractRopinirole, an agonist of the post-synaptic dopamine D2-receptor, exerts neuroprotective act...
As part of our long-term objective and continued efforts in developing an efficient multifunctional ...
The antiparkinsonian ropinirole and pramipexole are D3 receptor- (D3R-) preferring dopaminergic (DA)...
With L-DOPA, dopamine agonists such as pramipexole, ropinirole and rotigotine constitute key therape...
To date, the lack of highly selective antagonists at the dopamine D 3 receptor has hampered clarific...
A pharmacological and genetic blockade of the dopamine D3 receptor (D3R) has shown to be neuroprotec...
3-methyl-6-chloro-7,8-hydroxy-1-(3-methylphenyl)-2,3,4,5-tetrahydro-1H-3 - benzazepine (SKF83959), a...
Parkinson’s disease (PD) is characterized by a loss of dopaminergic neurons in the substantia nigra ...
Geniposide, a monomer extracted from gardenia and widely used in Chinese medicine, is a novel agonis...
We have investigated the ability of pramipexole, a dopamine agonist used in the symptomatic treatmen...
Parkinson’s disease is characterized by the loss of dopaminergic neurons in substantia nigra pars co...
Ginsenoside-Rg1, the pharmacologically active component isolated from ginseng, demonstrated neuropro...
Parkinson disease (PD) is a complex neurodegenerative disorder characterized by a progressive loss o...
Dopamine replacement therapy for Parkinson's disease is achieved using L-DOPA or dopamine D2/3 agoni...